Patent details

EP3452035 Title: POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE AND USES THEREOF

Basic Information

Publication number:
EP3452035
PCT Application Number:
US2017030414
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177930757
PCT Publication Number:
WO2017192451
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE AND USES THEREOF
French Title of Invention:
FORMES POLYMORPHES DE 3-[2-BUTYL-1-(2-DIÉTHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE ET LEURS UTILISATIONS
German Title of Invention:
POLYMORPHE FORMEN VON 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMID UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
01/05/2017
Grant date:
07/07/2021
EP Publication Date:
13/03/2019
PCT Publication Date:
09/11/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/07/2021
EP B1 Publication Date:
07/07/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/05/2022
Expiration date:
01/05/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/06/2021
 
 

Name:
MEI Pharma, Inc.
Address:
11455 El Camino Real, Suite 250, San Diego, CA 92130, United States (US)

Inventor

Name:
DUNCAN, David
Address:
United States (US)

Priority

Priority Number:
201662330673 P
Priority Date:
02/05/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07D 235/14; A61P 35/02; A61K 31/4184;

Publication

European Patent Bulletin

1

Issue number:
202127
Publication date:
07/07/2021
Description:
Grant (B1)

2

Issue number:
202128
Publication date:
14/07/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages